Posted 22nd July 2019 by Joshua Sewell
Following the Plant Genomics and Gene Editing Congress: Europe, we have made the following presentation slides from Ana Atanassova, Ian Bancroft, Nigel Halford and Kim Hammond-Kossack available.
Posted 28th June 2019 by Jane Williams
The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?
In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.
Posted 14th June 2019 by Joshua Sewell
Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.
Posted 29th March 2019 by Joshua Sewell
Günter Welz is part of the Open Innovation and Strategic Partnerships department at Bayer. He scouts for and builds relationships with external innovators in academia and business to enrich Bayer’s R&D pipeline, using various tools like the Open Innovation website and the venture capital arm.
Posted 20th August 2018 by Jane Williams
Degrading soil quality and increased interest in sustainable farming have caused the biostimulant market to go from strength-to-strength and it is expected to reach $4.14 billion by 2025.  Despite this, companies have expressed concerns that the regulation of biostimulants will hinder industry growth and the longevity of small companies and start-ups.
We spoke to Nick Moon, Global Regulatory Manager, Plant Impact, to discuss the regulation of biostimulants and its impact on industry.